Dannielle Appelhans - Director at HALOZYME THERAPEUTICS, INC.

Issuer-level insider activity

Role: Director
Issuer ticker: HALO on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Dannielle Appelhans since 05 Sep 2025

Reported holdings for Dannielle Appelhans in HALOZYME THERAPEUTICS, INC.

Form 4 holding Director

HALOZYME THERAPEUTICS, INC.

Security class: Option to Purchase Common Stock
Shares / value: 1,778
Estimated value
Report date: 01 Sep 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

HALOZYME THERAPEUTICS, INC.

Security class: Restricted Stock Units
Shares / value: 1,161
Estimated value
Report date: 01 Sep 2026
Price
Ownership: Direct

Transaction history for Dannielle Appelhans in HALOZYME THERAPEUTICS, INC.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .